IBD: Ulcerative Colitis
Biosimilars for IBD: Making the Transition Webinar
On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:
- What’s the difference between a reference biologic drug and a biosimilar?
- Biosimilars: What’s Health Canada saying?
- What is the clinical evidence to date?
- How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?
Watch this webinar now!
Related Articles
Ulcerative colitis is a chronic (long-term) condition with symptoms that can disappear and then flare up again throughout your life. Living with the unpredictable nature of […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
Hot off the Presses: The Latest IBD Information from Scientific Meetings with Dr. Silverberg Webinar
In this educational webinar, Dr. Silverberg reviewed the most recent scientific findings in Inflammatory Bowel Disease (IBD) and discussed the role of diet and gut bacteria […]